Search Results - "Sciuto, Tracey E"
-
1
Identification of extant vertebrate Myxine glutinosa VWF: evolutionary conservation of primary hemostasis
Published in Blood (07-12-2017)“…Hemostasis in vertebrates involves both a cellular and a protein component. Previous studies in jawless vertebrates (cyclostomes) suggest that the protein…”
Get full text
Journal Article -
2
Early Actions of Anti–Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels
Published in The American journal of pathology (01-10-2017)“…Tumors induce their heterogeneous vasculature by secreting vascular endothelial growth factor (VEGF)-A. Anti-VEGF/VEGF receptor (VEGFR) drugs treat cancer, but…”
Get full text
Journal Article -
3
Vascular Permeability and Pathological Angiogenesis in Caveolin-1-Null Mice
Published in The American journal of pathology (01-10-2009)“…Caveolin-1, the signature protein of endothelial cell caveolae, has many important functions in vascular cells. Caveolae are thought to be the transcellular…”
Get full text
Journal Article -
4
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Published in Cell (15-10-2020)“…Neoantigens arise from mutations in cancer cells and are important targets of T cell-mediated anti-tumor immunity. Here, we report the first open-label, phase…”
Get full text
Journal Article -
5
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer
Published in Cancer cell (12-09-2022)Get full text
Journal Article -
6
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Published in Cell (25-05-2023)“…T cell responses play an important role in protection against beta-coronavirus infections, including SARS-CoV-2, where they associate with decreased COVID-19…”
Get full text
Journal Article -
7
Mesenchymal Stem Cells Transmigrate Between and Directly Through Tumor Necrosis Factor-α-Activated Endothelial Cells Via Both Leukocyte-Like and Novel Mechanisms
Published in Stem cells (Dayton, Ohio) (01-11-2012)“…Systemically administered adult mesenchymal stem cells (MSCs), which are being explored in clinical trials to treat inflammatory disease, exhibit the critical…”
Get full text
Journal Article -
8
Probing the biomechanical contribution of the endothelium to lymphocyte migration: diapedesis by the path of least resistance
Published in Journal of cell science (01-09-2014)“…Immune cell trafficking requires the frequent breaching of the endothelial barrier either directly through individual cells ('transcellular' route) or through…”
Get full text
Journal Article -
9
TM4SF1: a tetraspanin-like protein necessary for nanopodia formation and endothelial cell migration
Published in Angiogenesis (London) (01-09-2011)Get full text
Journal Article -
10
Antigen recognition is facilitated by invadosome-like protrusions formed by memory/effector T cells
Published in The Journal of immunology (1950) (15-04-2012)“…Adaptive immunity requires that T cells efficiently scan diverse cell surfaces to identify cognate Ag. However, the basic cellular mechanisms remain unclear…”
Get full text
Journal Article -
11
ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow
Published in Blood (15-07-2005)“…In vivo, leukocyte transendothelial migration (TEM) occurs at endothelial cell junctions (paracellular) and nonjunctional (transcellular) locations, whereas in…”
Get full text
Journal Article -
12
Transcellular Diapedesis Is Initiated by Invasive Podosomes
Published in Immunity (Cambridge, Mass.) (01-06-2007)“…Diapedesis is critical for immune system function and inflammatory responses. This occurs by migration of blood leukocytes either directly through individual…”
Get full text
Journal Article -
13
TM4SF1: a new vascular therapeutic target in cancer
Published in Angiogenesis (London) (01-10-2014)“…Transmembrane-4 L -six family member-1 (TM4SF1) is a small plasma membrane glycoprotein that regulates cell motility and proliferation. TM4SF1 is an attractive…”
Get full text
Journal Article -
14
Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability
Published in Blood (13-09-2012)“…VEGF induces vascular permeability (VP) in ischemic diseases and cancer, leading to many pathophysiological consequences. The molecular mechanisms by which…”
Get full text
Journal Article -
15
Intracellular distribution of TM4SF1 and internalization of TM4SF1-antibody complex in vascular endothelial cells
Published in Biochemical and biophysical research communications (25-09-2015)“…Transmembrane-4 L-six family member-1 (TM4SF1) is a small plasma membrane-associated glycoprotein that is highly and selectively expressed on the plasma…”
Get full text
Journal Article -
16
TM4SF1: a tetraspanin-like protein necessary for nanopodia formation and endothelial cell migration
Published in Angiogenesis (London) (01-09-2011)“…Transmembrane-4-L-six-family-1 (TM4SF1) is a tetraspanin-like membrane protein that is highly and selectively expressed by cultured endothelial cells (EC) and,…”
Get full text
Journal Article -
17
Adoptive transfer of mast cells does not enhance the impaired survival of Kit(W)/Kit(W-v) mice in a model of low dose intraperitoneal infection with bioluminescent Salmonella typhimurium
Published in Immunology letters (15-06-2005)“…Mast cells are important effector cells in IgE-associated immune responses, but also can contribute to host defense in certain examples of bacterial infection…”
Get full text
Journal Article -
18
Abstract 73: A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first-line non-squamous NSCLC: Associations with clinical outcomes
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Background: Neoantigens arising from mutations in cancer cell DNA are important targets for T cell-mediated anti-tumor immunity. NEO-PV-01 is a…”
Get full text
Journal Article -
19
Abstract 5006: Comprehensive gene expression analysis of the tumor microenvironment in patients with advanced cancer treated with a personalized neoantigen vaccine, NEO-PV-01, in combination with anti-PD1
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Background: Neoantigens arise from DNA mutations in cancer cells and are important targets for T cell mediated anti-tumor immunity. NEO-PV-01 is a…”
Get full text
Journal Article -
20
Abstract 942: The personalized vaccine, NEO-PV-01 with anti-PD1, induces neoantigen-specific de novo immune responses in patients with advanced metastatic melanoma: Association with clinical outcomes
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Background: Neoantigens arise from DNA mutations in cancer cells and are important targets for T cell mediated anti-tumor immunity. NEO-PV-01 is a…”
Get full text
Journal Article